Clozapine, norclozapine plasma levels, their sum and ratio in 50 psychotic patients: Influence of patient-related variables

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 26, Issue 3, 2002, Pages 473-480

  Palego, Lionella ^a   Biondi, Luciano ^a   Giannaccini, Gino ^a   Sarno, Nannina ^a   Elmi, Simona ^a   Ciapparelli, Antonio ^a   Cassano, Giovanni Battista ^a   Lucacchini, Antonio ^a   Martini, Claudia ^a   Dell'Osso, Liliana ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Clozapine; Norclozapine; Patient related variables; Plasma levels

Indexed keywords

BROMPERIDOL; CLOZAPINE; HALOPERIDOL; NORCLOZAPINE; RISPERIDONE; ZUCLOPENTHIXOL;

ADULT; AGE; AGED; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; FEMALE; GENDER; HUMAN; MALE; METABOLITE; PARAMETER; PSYCHOSIS; REVERSED PHASE LIQUID CHROMATOGRAPHY; SMOKING; STEADY STATE; ULTRAVIOLET RADIATION;

ADOLESCENT; ADULT; AGED; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENTS; PSYCHOTIC DISORDERS; SEX FACTORS; SMOKING; STATISTICS, NONPARAMETRIC;

EID: 0036198889     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(01)00291-3     Document Type: Article

References (40)

1. Clozapine - Pharmacokinetic investigators and biochemical effect in men
2. Antipsychotische wirksamkeit him verhaltnis zum plasmaspiegel von clozapin
3. Clozapine induced agranulocytosis: Incidence and risk factors in the United States
4. Determination of clozapine and its N-demethylated metabolites in plasma by use of gas chromatography mass spectrometry with single ion detection
5. Clozapine prophylaxis in rapid cycling bipolar disorder
6. Clozapine for treatment-refractory mania
7. Clozapine as a treatment tool: Only in resistant schizophrenic patients?
8. Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolites
9. Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors
10. Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: A 24-month naturalistic study
11. Evaluation of treatment-resistant schizophrenia
12. Disposition of clozapine in man: Lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphism
13. Clozapine: An atypical antipsychotic agent
14. Effect of treatment duration on plasma levels of clozapine and N-desmethylclozapine in men and women
15. The antipsychotic clozapine is metabolized by the polymorphic human microsomal and recombinant cytochrome P450 2D6
16. N-desmethylclozapine: A clozapine metabolite that suppresses haemopoiesis
17. Dose-related plasma levels of clozapine: Influence of smoking behavior, sex and age
18. Influence of patient-related variables on clozapine plasma levels
19. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: Effect of smoking
20. Gender differences in plasma clozapine levels and its metabolites in schizophrenics patients
21. Clozapine for the treatment-resistant schizophrenics
22. Effects of gender and age on plasma levels of clozapine and its metabolites: Analyzed by critical statistics
23. The assay of clozapine and N-desmethylclozapine in human plasma by high-performance liquid chromatography
24. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorders and schizophrenia
25. A prospective study of clozapine in treatment-resistant schizophrenic patients: I. Preliminary report
26. Clozapine: New research on efficacy and mechanism of action
27. Simultaneous analysis of clozapine, clomipramine and their metabolites by reversed-phase liquid chromatography
28. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients
29. Cigarette smoking and clinically significance drug interactions
30. Clozapine serum concentrations are lower in smoking than in non-smoking schizophrenic patients
31. Effect of antipsychotic drugs on human liver cytochrome P-450 (CYP) isoforms in vitro: Preferential inhibition of CYP2D6
32. Potent inhibition of CYP2D6 by haloperidol metabolites: Stereoselective inhibition by reduced haloperidol
33. Antipsychotic polypharmacy: Part I. Therapeutic option or dirty little secret?
34. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics
35. Determination of clozapine, norclozapine and clozapine-N-oxide in serum by liquid chromatography
36. Determination of clozapine and its major metabolites in human serum using automated solid-phase extraction and subsequent isocratic high performance liquid chromatography with ultraviolet detection
37. Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: Differential effects of fluvoxamine and paroxetine in a prospective study
38. The expanding indications for clozapine
39. Is clozapine a mood stabilizer?